The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Failure at task-specific regional brain activation: new conceptualization of a disease entity

Published Online:https://doi.org/10.1176/jnp.3.1.94

The current diagnostic system in psychiatry is symptom-based, as described in detail in DSM-III-R. In other branches of medicine the logic of diagnosis is based on knowledge of the normal function of the organ system affected by disease, and direct measures of pathophysiological process play an increasingly important role in clinical practice. New understanding of normal brain function has opened the way for psychiatry to begin to follow this path and develop a brain-based, rather than symptom-based, nosology. Different models of normal brain function, however, suggest quite different theoretical and research approaches. One way in which these models differ is the degree to which they link specific functions (and illnesses) to specific anatomic locations. In a previous paper I discussed the value of adopting a model of brain function that includes important roles for the processes that integrate multiple brain regions into ever-changing functional constellations. In this paper I have proposed the existence of a disease characterized by abnormality in the general physiological mechanism of task-specific regional brain activation. This is not an etiologic diagnosis and therefore presents nothing more than a symptom- based diagnosis about the cause of the disorder. However, I predict that this diagnosis will define a group of patients that is more homogeneous with respect to both clinical course and etiology than do the current symptom-based diagnoses to which these patients would otherwise be assigned. Furthermore, it may be possible to develop new treatments to address this physiological dysfunction.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.